Orchestra BioMed Inc.

5.55
-0.04 (-0.72%)
At close: Jan 28, 2025, 2:13 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue 2.76M 3.53M -782.00K 5.70M
Cost of Revenue 186.00K 322.00K 199.00K 145.00K
Gross Profit 2.57M 3.21M -981.00K 5.56M
Operating Income -51.51M -32.66M -21.80M -18.75M
Interest Income 3.85M 50.00K 927.00K 331.00K
Pretax Income -49.12M -33.61M -23.01M -21.36M
Net Income -49.12M -33.61M -23.01M -21.36M
Selling & General & Admin 20.26M 13.92M 7.93M 10.83M
Research & Development 33.82M 21.95M 12.89M 13.48M
Other Expenses n/a n/a n/a n/a
Operating Expenses 54.08M 35.87M 20.82M 24.31M
Interest Expense n/a n/a 927.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 54.27M 36.19M 21.02M 24.45M
Income Tax n/a -222.00K 927.00K 2.60M
Shares Outstanding (Basic) 33.23M 14.99M 20.45M 20.45M
Shares Outstanding (Diluted) 33.23M 14.99M 20.45M 20.45M
EPS (Basic) -1.48 -2.24 -1.13 -1.04
EPS (Diluted) -1.48 -2.24 -1.13 -1.04
EBITDA -51.22M -32.44M -21.62M -18.61M
Depreciation & Amortization 287.00K 222.00K 181.00K 137.00K